Alberta Investment Management Corp Alnylam Pharmaceuticals, Inc. Transaction History

Alberta Investment Management Corp

$10.2 Billion
Q3 2024

A detailed history of Alberta Investment Management Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Alberta Investment Management Corp holds 6,900 shares of ALNY stock, worth $1.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,900

Holding current value

$1.7 Million

% of portfolio

0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$233.81 - $287.01 $1.61 Million - $1.98 Million	6,900 New	6,900 $1.9 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $626,330 - $847,305	-4,275 Reduced 59.58%	2,900 $433,000
Q4 2023 Feb 12, 2024	BUY	$151.41 - $196.57 $647,277 - $840,336	4,275 Added 147.41%	7,175 $1.37 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $529,714 - $683,037	2,900 New	2,900 $580,000
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $14.4 Million - $17.6 Million	-84,800 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $514,520 - $707,560	-4,000 Reduced 4.5%	84,800 $14.4 Million
Q1 2021 May 07, 2021	SELL	$126.83 - $175.69 $697,565 - $966,295	-5,500 Reduced 5.83%	88,800 $12.5 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $1.64 Million - $1.96 Million	13,300 Added 16.42%	94,300 $12.3 Million
Q3 2020 Oct 26, 2020	BUY	$121.19 - $165.49 $1.27 Million - $1.74 Million	10,500 Added 14.89%	81,000 $11.8 Million
Q2 2020 Aug 11, 2020	BUY	$104.21 - $156.44 $1.93 Million - $2.89 Million	18,500 Added 35.58%	70,500 $10.4 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $849,414 - $1.42 Million	-11,400 Reduced 17.98%	52,000 $5.99 Million
Q3 2019 Oct 23, 2019	SELL	$70.9 - $87.82 $1.74 Million - $2.15 Million	-24,500 Reduced 27.87%	63,400 $5.1 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $1.84 Million - $2.59 Million	27,900 Added 46.5%	87,900 $6.38 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $4.37 Million - $5.61 Million	60,000 New	60,000 $5.61 Million
Q2 2018 Aug 15, 2018	SELL	$88.31 - $107.8 $4.96 Million - $6.06 Million	-56,200 Closed	0 $0
Q1 2018 May 16, 2018	BUY	$115.92 - $148.54 $5.16 Million - $6.61 Million	44,500 Added 380.34%	56,200 $6.69 Million
Q4 2017 Feb 15, 2018	SELL	$114.49 - $139.98 $858,675 - $1.05 Million	-7,500 Reduced 39.06%	11,700 $1.49 Million
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $1.39 Million - $2.27 Million	19,200	19,200 $2.26 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Account

Alberta Investment Management Corp Alnylam Pharmaceuticals, Inc. Transaction History